MGO One Seven’s Fortress Biotech FBIO Stock Holding History

MGO One Seven’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1K	Hold	15	–	–	﹤0.01%	1652
2017 Q4	$1K	Buy	+15	New	+$883	﹤0.01%	1631

Other funds holding FBIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

MGO One Seven's FBIO Position: Q1 2018 in Review

MGO One Seven held its Fortress Biotech (FBIO) position steady in Q1 2018 at 15 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1652.

MGO One Seven first reported a position in FBIO in Q4 2017 and has held it in 2 quarters since. 66 funds tracked by Wall St. Rank hold FBIO as of Q1 2018.

MGO One Seven held 15 shares of Fortress Biotech worth $1K as of Q1 2018.
MGO One Seven left its Fortress Biotech share count unchanged in Q1 2018.
Fortress Biotech made up ﹤0.01% of MGO One Seven's portfolio in Q1 2018, its #1652 holding.
MGO One Seven first reported a position in Fortress Biotech in Q4 2017 and has held it in 2 quarters since.
66 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2018.

Based on MGO One Seven's 13F filing for Q1 2018, filed 15 May 2018.